Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?
作者信息
Tisch R, McDevitt H O
机构信息
Department of Microbiology and Immunology, Stanford University Medical Center, CA 94305-5402.
出版信息
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):437-8. doi: 10.1073/pnas.91.2.437.
Abstract
摘要
相似文献
1
Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?抗原特异性免疫疗法：对抗T细胞介导的自身免疫是否真的可行？
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):437-8. doi: 10.1073/pnas.91.2.437.
2
Therapeutic intervention in autoimmunity.自身免疫性疾病的治疗干预。
Behring Inst Mitt. 1994 Jul(94):171-8.
3
The development of antigen specific therapies for autoimmune diseases; investigations in multiple sclerosis as a paradigm for rheumatoid arthritis.自身免疫性疾病抗原特异性疗法的发展；以多发性硬化症为类风湿性关节炎范例的研究。
Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S39-40.
4
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.自身免疫中的共刺激和共抑制途径。
Immunity. 2016 May 17;44(5):1034-51. doi: 10.1016/j.immuni.2016.04.017.
5
Rational development of antigen-specific therapies for type 1 diabetes.1型糖尿病抗原特异性疗法的合理开发。
Adv Exp Med Biol. 2007;601:313-9. doi: 10.1007/978-0-387-72005-0_34.
6
Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis?树突状细胞：类风湿关节炎自身免疫背后的驱动力？
Immunol Cell Biol. 1999 Oct;77(5):420-7. doi: 10.1046/j.1440-1711.1999.00855.x.
7
Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances.1 型糖尿病的肽免疫疗法——临床进展。
Front Immunol. 2018 Feb 28;9:392. doi: 10.3389/fimmu.2018.00392. eCollection 2018.
8
Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.糖尿病抗原特异性 T 细胞分析——临床前研究和早期临床试验的经验教训。
J Autoimmun. 2016 Jul;71:35-43. doi: 10.1016/j.jaut.2016.03.018. Epub 2016 Apr 12.
9
Systemic antigen in the treatment of T-cell-mediated autoimmune diseases.全身性抗原在T细胞介导的自身免疫性疾病治疗中的应用。
Immunol Today. 1997 Dec;18(12):599-604. doi: 10.1016/s0167-5699(97)01171-7.
10
The role of autoantigens in the driving of autoimmune diseases.自身抗原在自身免疫性疾病发病机制中的作用。
Immunol Ser. 1993;59:119-29.
引用本文的文献
1
Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.抗原阵列的结构、大小和溶解性决定了实验性自身免疫性脑脊髓炎的疗效。
AAPS J. 2014 Nov;16(6):1185-93. doi: 10.1208/s12248-014-9654-z. Epub 2014 Sep 6.
2
Inducing immune tolerance: a focus on Type 1 diabetes mellitus.诱导免疫耐受：聚焦于1型糖尿病
Diabetes Manag (Lond). 2013 Sep 1;3(5):415-426. doi: 10.2217/dmt.13.36.
3
GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes.1 型糖尿病患儿和青少年使用 GAD 铝佐剂治疗后的 GAD 自身抗体表位模式。
Pediatr Diabetes. 2012 May;13(3):244-50. doi: 10.1111/j.1399-5448.2011.00802.x. Epub 2011 Aug 16.
4
Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.用于重建1型糖尿病患者T细胞耐受性的基因疫苗接种
Hum Vaccin. 2011 Jan 1;7(1):27-36. doi: 10.4161/hv.7.1.12848.
5
Transgenically induced GAD tolerance curtails the development of early beta-cell autoreactivities but causes the subsequent development of supernormal autoreactivities to other beta-cell antigens.转基因诱导的谷氨酸脱羧酶耐受性可抑制早期β细胞自身反应性的发展，但会导致随后对其他β细胞抗原产生超常自身反应性。
Diabetes. 2009 Dec;58(12):2843-50. doi: 10.2337/db08-0851. Epub 2009 Sep 9.
6
Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice.GAD65特异性自身免疫的归巢和胰岛炎的发展需要转基因小鼠同时表达DQ8和人GAD65。
J Autoimmun. 2009 Aug;33(1):50-7. doi: 10.1016/j.jaut.2009.02.004. Epub 2009 Mar 16.
7
Parameters influencing antigen-specific immunotherapy for Type 1 diabetes.影响1型糖尿病抗原特异性免疫治疗的参数。
Immunol Res. 2008;42(1-3):246-58. doi: 10.1007/s12026-008-8090-5.
8
Parameters influencing antigen-specific immunotherapy for type 1 diabetes.影响1型糖尿病抗原特异性免疫治疗的参数。
Immunol Res. 2008;41(3):175-87. doi: 10.1007/s12026-008-8020-6.
9
Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes.将人源或猪源口服胰岛素与霍乱毒素（CTB）的B亚基偶联，可克服关键的抗原差异，从而预防I型糖尿病。
Clin Exp Immunol. 2003 Oct;134(1):38-45. doi: 10.1046/j.1365-2249.2003.02255.x.
10
Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.对谷氨酸脱羧酶耐受的非肥胖糖尿病（NOD）小鼠中糖尿病的正常发病率。
J Exp Med. 2003 Jun 16;197(12):1635-44. doi: 10.1084/jem.20030215. Epub 2003 Jun 9.
本文引用的文献
1
Effects of oral administration of type II collagen on rheumatoid arthritis.口服II型胶原蛋白对类风湿性关节炎的影响。
Science. 1993 Sep 24;261(5129):1727-30. doi: 10.1126/science.8378772.
2
Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model.肽诱导的T细胞耐受性在转基因小鼠模型中预防自身免疫性糖尿病
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):444-8. doi: 10.1073/pnas.91.2.444.
3
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.对谷氨酸脱羧酶的免疫反应与非肥胖糖尿病小鼠的胰岛炎相关。
Nature. 1993 Nov 4;366(6450):72-5. doi: 10.1038/366072a0.
4
Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.小鼠胰岛素依赖型糖尿病中T细胞对谷氨酸脱羧酶的自发耐受性丧失。
Nature. 1993 Nov 4;366(6450):69-72. doi: 10.1038/366069a0.
5
Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.自身免疫性脑脊髓炎中的抗原识别及肽介导免疫疗法的潜力。
Cell. 1989 Oct 20;59(2):247-55. doi: 10.1016/0092-8674(89)90287-0.
6
Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein.肽特异性预防实验性变应性脑脊髓炎。对髓鞘碱性蛋白主要T细胞决定簇诱导的新生期耐受。
J Exp Med. 1989 May 1;169(5):1681-91. doi: 10.1084/jem.169.5.1681.
7
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.口服髓鞘碱性蛋白对实验性自身免疫性脑脊髓炎的抑制作用。II. 疾病抑制和体外免疫反应由抗原特异性CD8 + T淋巴细胞介导。
J Immunol. 1989 Feb 1;142(3):748-52.
8
9
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.通过口服S抗原诱导耐受来抑制S抗原诱导的实验性自身免疫性葡萄膜视网膜炎。
J Immunol. 1990 Mar 1;144(5):1689-95.
10
Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.口服II型胶原蛋白对Lewis大鼠佐剂性关节炎的抑制作用
J Immunol. 1990 Oct 15;145(8):2489-93.
Zotero 插件